When.com Web Search

  1. Ads

    related to: is there a cure for herpes simplex 2

Search results

  1. Results From The WOW.Com Content Network
  2. Herpes simplex research - Wikipedia

    en.wikipedia.org/wiki/Herpes_simplex_research

    Herpes simplex research includes all medical research that attempts to prevent, treat, or cure herpes, as well as fundamental research about the nature of herpes. Examples of particular herpes research include drug development , vaccines and genome editing.

  3. A Breakthrough in Gene Editing Offers Hope for a Cure for ...

    www.aol.com/lifestyle/breakthrough-gene-editing...

    Herpes simplex 2, the virus usually responsible for genital herpes, can cause oral herpes infections, too—you might imagine how. Once infected with oral herpes, most people show no symptoms ...

  4. Herpes simplex virus - Wikipedia

    en.wikipedia.org/wiki/Herpes_simplex_virus

    Herpes simplex 2 genomes can be divided into two groups: one is globally distributed and the other is mostly limited to sub Saharan Africa. [59] The globally distributed genotype has undergone four ancient recombinations with herpes simplex 1. It has also been reported that HSV-1 and HSV-2 can have contemporary and stable recombination events ...

  5. Herpes - Wikipedia

    en.wikipedia.org/wiki/Herpes

    Herpes simplex, often known simply as herpes, is a viral infection caused by the herpes simplex virus. [5] Herpes infections are categorized by the area of the body that is infected. The two major types of herpes are oral herpes and genital herpes , though other forms also exist.

  6. Herpes infects billions of people worldwide. Why isn't there ...

    www.aol.com/news/herpes-infects-billions-people...

    About half a billion people ages 15 to 49 have genital herpes infections, which are mostly caused by herpes simplex virus type 2, which can raise the risk of HIV. Herpes infections can lead to ...

  7. Pritelivir - Wikipedia

    en.wikipedia.org/wiki/Pritelivir

    Pritelivir (development codes AIC316 or BAY 57-1293) is a direct-acting antiviral drug in development for the treatment of herpes simplex virus infections (HSV). This is particularly important in immune compromised patients. It is currently in Phase III clinical development by the German biopharmaceutical company AiCuris Anti-infective Cures AG.